PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Swallowfield, Perpetual Income & Growth IT

Mon, 14th Jun 2010 12:22

Shares in Swallowfield, a supplier of cosmetics and toiletries to the own label and branded sectors, dropped after the group warned that trading in the second half will be below expectations.Perpetual Income and Growth Investment Trust's shares produced a total return of 31% to shareholders over the 12 months to 31 March, while the total return of the company's benchmark for performance measuring purposes, the FTSE All-Share Index, was 52.3%. Drug developer Phytopharm has been given the go-ahead for a phase two trial of its Parkinson's disease treatment Cogane by the US Food and Drug Administration. The study will investigate the efficacy, safety and tolerability of Cogane administered for 28 weeks to patients with early stage Parkinson's disease.Nexus Management has issued £175,000 worth of convertible loan notes to the SF t1PS Smaller Companies Growth Fund. Interest is 10% per annum, payable quarterly in arrears. The company has also issued to SF t1ps £200,000 of warrants exercisable until June 2011 at 0.35p per share of which £50,000 will be exercised immediately.The company has also reached an agreement with VPEP, which will accept a total of $335,000 in satisfaction of approximately $525,000 of debt.Executive search firm Gartner said its Norman Broadbent subsidiary is forming a joint venture with Russam GMS. The new company will be called NB: Board Interim and will specialise in the provision of interim board executives.The joint venture will initially focus on capitalising on Norman Broadbent's experience through their Executive Search business in the financial services, public sector and healthcare, engineering, manufacturing and construction, technology and telecoms, and media sectors.East Russia-focused Amur Minerals has found nickel and copper mineralisation in a road cut immediately to the south of the Ikenskoe deposit, the largest of the three drilled deposits within the Kun Manie exploration licence. "This find confirms our belief that Ikenskoe could be substantially larger than presently reported, and our initial expectations are that the mineralisation extends both to the east and south of the known deposits," said boss Robin Young.Uranium Resources has started drilling on its Mtonya prospect in Tanzania, a known uraniferous district which has yielded the Nyota deposit for Mantra Resources.The two-phase drilling programme will comprise approximately 3,000m in two drill fences. Phase 1 will drill 1,500m and complete late July/early August, with Phase 2 carried out between August and October.Akers Biosciences, a maker of diagnostic screening and testing products, has signed a contract with US healthcare distribution group Fisher to supply its PIFA Heparin/PF4 Rapid Assay product, which is used to detect if a patient being treated with the blood thinner Heparin may be developing a drug allergy.
More News
25 Jun 2014 11:44

UK WINNERS & LOSERS: REIT's Rise On Carney Message, Sector Activity

Read more
25 Jun 2014 11:33

Akers Biosciences Inks Distribution Agreement With Medline Industries

Read more
4 Jun 2014 11:11

Akers Biosciences Inks Sales And Distribution Agreement With Typenex

LONDON (Alliance News) - Akers Biosciences Inc said Wednesday that it had inked a sales and distribution agreement with Typenex Medical LLC for its PIFA Heparin/PF4 and PIFA PLUSS Platelet Factor 4 test kits. Akers said that the agreement was part of its strategy to accelerate sales of the

Read more
4 Jun 2014 08:09

Akers Biosciences signs distribution deal with US sales firm

Akers Biosciences, which manufactures rapid diagnostic screening and testing products, has entered into a sales and distribution agreement with US-based Typenex Medical, a product development and sales organisation. Under the contract, which can be renewed after one year by mutual consent, the gro

Read more
4 Jun 2014 07:25

UK MORNING BRIEFING: Tesco Reports Sales Decline Amid Price Cutting

LONDON (Alliance News) - UK shares have opened mostly lower, with small-caps slightly outperforming Wednesday ahead of the Queen's Speech and further European economic data.

Starting the trading day on a negative note, Tesco PLC reported a sharp drop in sales in the

Read more
16 May 2014 11:33

Akers Biosciences Inks India Marketing Agreement With Jai Capital

LONDON (Alliance News) - Akers Biosciences Inc said Friday that it had inked an agreement with Nevada-based Jai Capital LLC to market its rapid test products in India. Under the agreement Jai will market Aker's PIFA Heparin/Platelet Factor-4 Rapid Assay test for thrombosis, its PIFA Dengue

Read more
16 May 2014 08:05

Akers Biosciences to launch new product in India

AIM-listed healthcare equipment firm Akers Biosciences has entered into an agreement with medical devices market developer Jai Capital to launch the group's PIFA Heparin/Platele in India. The Nevada-based group will market the company's product to the Indian military, which is allowed to buy produc

Read more
14 May 2014 11:14

Akers Biosciences Profit Hit By IPO Costs, But Revenue More Than Doubles

LONDON (Alliance News) - Akers Biosciences Inc, which recently listed on Nasdaq, Wednesday reported a first-quarter net loss of USD595,600, mainly due to the costs of the initial public offering. The maker of rapid diagnostic screening and testing products, which is also listed on London's

Read more
7 May 2014 11:19

Akers Biosciences Adds New Distributor For Diseases Tests

LONDON (Alliance News) - Akers Biosciences Inc Wednesday said it had signed a deal whereby Dubai-based Thirty Six Strategies General Trading LLC will sell Akers' infectious diseases tests exclusively for the next three years in some countries. In a statement, Akers said the exclusive agreem

Read more
7 May 2014 10:54

Akers Biosciences arranges Australia and UAE distribution deal

AIM- and Nasdaq-listed healthcare equipment firm Akers Biosciences has signed a three-year distribution agreement to sell its products in Australia, Singapore, the United Arab Emirates and Oman. Dubai-based procurement company, 36S, will immediately begin marketing Aker's PIFA PLUSS infectious dis

Read more
30 Apr 2014 14:19

Akers Biosciences Begins Trial For Chlamydia Assay

LONDON (Alliance News) - Akers Biosciences Inc said Wednesday that it has begun clinical trials in the US for its PIFA PLUSS chlamydia assay, a test for chlamydia diagnosis using a finger stick blood sample. The study will include 200 to 250 patients in total, including normal, newly infect

Read more
28 Mar 2014 12:38

Akers Biosciences Loss Narrows As Breathalysers Boost Revenues

LONDON (Alliance News) - Akers Biosciences Inc Friday posted a narrowed pretax loss for 2013, as it saw revenues more than double, driven by sales of its breathalyser products, and expressed confidence for 2014 following its dual listing in New York in January. The company posted a pretax l

Read more
12 Mar 2014 17:23

Akers Biosciences CEO To Step Down

LONDON (Alliance News) Akers Biosciences Wednesday said Chief Executive Thomas Nicolette will step down from the board and leave the company on March 28. Nicolette, who has been at the helm since 2008, will be replaced by Executive Chairman Raymond Akers. The stock closed at 340.00 pe

Read more
24 Jan 2014 12:41

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Ec

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.